Suzuken Future Growth
Future criteria checks 0/6
SuzukenSe prevé que los beneficios de la empresa disminuyan en 0.8% al año, mientras que sus ingresos anuales crecerán en 1.4% al año. Se prevé que el BPA se sitúe en grow a una tasa anual de 1.7%. Se prevé que la rentabilidad de los fondos propios sea de 4.8% en 3 años.
Key information
-1.1%
Earnings growth rate
1.1%
EPS growth rate
Healthcare earnings growth | 10.0% |
Revenue growth rate | 1.9% |
Future return on equity | 4.8% |
Analyst coverage | Low |
Last updated | 13 Mar 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 2,481,449 | 23,987 | 21,607 | N/A | 3 |
3/31/2026 | 2,405,819 | 22,360 | 21,256 | N/A | 5 |
3/31/2025 | 2,363,671 | 21,132 | 17,939 | N/A | 5 |
3/31/2024 | 2,325,068 | 23,563 | 51,000 | N/A | 5 |
12/31/2023 | 2,371,225 | 27,681 | N/A | N/A | N/A |
9/30/2023 | 2,370,990 | 25,379 | 81,312 | 95,165 | N/A |
6/30/2023 | 2,334,718 | 21,006 | N/A | N/A | N/A |
3/31/2023 | 2,314,828 | 20,345 | 19,528 | 37,270 | N/A |
12/31/2022 | 2,306,580 | 19,310 | N/A | N/A | N/A |
9/30/2022 | 2,273,513 | 16,065 | 7,158 | 22,765 | N/A |
6/30/2022 | 2,247,385 | 17,506 | N/A | N/A | N/A |
3/31/2022 | 2,232,774 | 14,393 | -4,772 | 9,520 | N/A |
12/31/2021 | 2,205,199 | 15,033 | N/A | N/A | N/A |
9/30/2021 | 2,183,487 | 12,694 | 15,796 | 29,182 | N/A |
6/30/2021 | 2,150,734 | 9,041 | N/A | N/A | N/A |
3/31/2021 | 2,128,218 | 7,895 | 7,738 | 15,602 | N/A |
12/31/2020 | 2,133,976 | 14,012 | N/A | N/A | N/A |
9/30/2020 | 2,141,519 | 19,394 | 40,694 | 49,275 | N/A |
6/30/2020 | 2,183,542 | 22,641 | N/A | N/A | N/A |
3/31/2020 | 2,213,478 | 28,213 | -37,515 | -25,817 | N/A |
12/31/2019 | 2,214,475 | 26,263 | N/A | N/A | N/A |
9/30/2019 | 2,214,861 | 34,177 | -59,889 | -48,665 | N/A |
6/30/2019 | 2,159,354 | 33,533 | N/A | N/A | N/A |
3/31/2019 | 2,132,362 | 30,204 | 32,932 | 41,751 | N/A |
12/31/2018 | 2,111,244 | 28,126 | N/A | N/A | N/A |
9/30/2018 | 2,108,847 | 20,925 | 34,710 | 42,874 | N/A |
6/30/2018 | 2,115,937 | 16,386 | N/A | N/A | N/A |
3/31/2018 | 2,123,997 | 18,820 | 90,120 | 98,066 | N/A |
12/31/2017 | 2,130,453 | 18,807 | N/A | N/A | N/A |
9/30/2017 | 2,118,731 | 21,894 | N/A | 82,635 | N/A |
6/30/2017 | 2,121,761 | 23,333 | N/A | N/A | N/A |
3/31/2017 | 2,126,993 | 21,308 | N/A | 27,013 | N/A |
12/31/2016 | 2,186,665 | 26,534 | N/A | N/A | N/A |
9/30/2016 | 2,247,810 | 26,403 | N/A | 29,952 | N/A |
6/30/2016 | 2,251,839 | 26,925 | N/A | N/A | N/A |
3/31/2016 | 2,228,331 | 28,960 | N/A | 20,457 | N/A |
12/31/2015 | 2,149,121 | 24,043 | N/A | N/A | N/A |
9/30/2015 | 2,066,204 | 21,320 | N/A | 35,474 | N/A |
6/30/2015 | 2,017,824 | 20,122 | N/A | N/A | N/A |
3/31/2015 | 1,969,689 | 18,920 | N/A | 47,209 | N/A |
12/31/2014 | 1,977,291 | 21,296 | N/A | N/A | N/A |
9/30/2014 | 1,968,911 | 20,219 | N/A | 32,094 | N/A |
6/30/2014 | 1,968,813 | 19,905 | N/A | N/A | N/A |
3/31/2014 | 1,988,216 | 21,447 | N/A | -41,054 | N/A |
12/31/2013 | 1,952,023 | 22,495 | N/A | N/A | N/A |
9/30/2013 | 1,933,492 | 21,252 | N/A | -18,784 | N/A |
6/30/2013 | 1,913,189 | 16,163 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Ingresos vs. tasa de ahorro: 9987Se prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-0.8% al año).
Beneficios frente mercado: 9987Se prevé que los beneficios de la empresa disminuyan en los próximos 3 años (-0.8% al año).
Beneficios de alto crecimiento: 9987Se prevé que los beneficios de la empresa disminuyan en los próximos 3 años.
Ingresos vs. Mercado: 9987(1.4% al año) se prevé que crezca más despacio que el mercado de JP (4% al año).
Ingresos de alto crecimiento: 9987Se prevé que los ingresos de la empresa (1.4% al año) crezcan más despacio que 20% al año.
Earnings per Share Growth Forecasts
Future Return on Equity
Futura rentabilidad financiera (ROE): 9987Se prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (4.8%).